Acadian Asset Management
DSCI

Acadian Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Acadian Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,618
Closed -$8K – 1893
2016
Q3 		$8K Buy
+1,618
New +$7.55K ﹤0.01% 1270
2016
Q1 		– Sell
-6,893
Closed -$32K – 1641
2015
Q4 		$32K Buy
+6,893
New +$32.7K ﹤0.01% 1146

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Acadian Asset Management's DSCI Position: Q4 2016 in Review

Acadian Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 1,618 shares — an estimated $8K sold.

Acadian Asset Management first reported a position in DSCI in Q4 2015 and held it in 2 quarters. The position peaked at $32K in Q4 2015. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

  • Acadian Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
  • Acadian Asset Management sold 1,618 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $8K.
  • Acadian Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 2 quarters.
  • Acadian Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $32K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Acadian Asset Management's 13F filing for Q4 2016, filed 19 Jan 2017.